These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24279470)

  • 1. The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease.
    Guo L; Jiang F; Tang YT; Si MY; Jiao XY
    Diabetes Technol Ther; 2014 Apr; 16(4):224-34. PubMed ID: 24279470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.
    Zhang Q; Fang W; Ma L; Wang ZD; Yang YM; Lu YQ
    Medicine (Baltimore); 2018 Apr; 97(15):e0415. PubMed ID: 29642210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BuZangTongLuo decoction improved hindlimb ischemia by activating angiogenesis and regulating gut microbiota in diabetic mice.
    Zheng J; Chen M; Ye C; Sun X; Jiang N; Zou X; Yang H; Liu H
    J Ethnopharmacol; 2020 Feb; 248():112330. PubMed ID: 31654796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of iron stores to oxidative stress in type 2 diabetes.
    Kundu D; Roy A; Mandal T; Bandyopadhyay U; Ghosh E; Ray D
    Niger J Clin Pract; 2013; 16(1):100-3. PubMed ID: 23377481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
    Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin levels in poorly- and well-controlled diabetes mellitus.
    Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ
    Endocr Res; 2003 Aug; 29(3):299-306. PubMed ID: 14535631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of insulin-like growth factor I and hypoxia inducible factor 1α in vascular endothelial growth factor expression in type 2 diabetes.
    Jiang F; Tang YT; Guo L; Jiao XY
    Ann Clin Lab Sci; 2013; 43(1):37-44. PubMed ID: 23462604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hypoxia Inducible Factor -1 Alpha and Vascular Endothelial Growth Factor Level in Type 2 Diabetes Microvascular Complications and Development.
    Rusdiana R; Moradi A; Widjaja SS; Sari MI; Hidayat H; Savira M; Amelia R; Rusmalawaty R
    Med Arch; 2022 Apr; 76(2):135-139. PubMed ID: 35774047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
    Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
    Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension.
    Cipriani R; Sensi M; Gabriele A; Gatti A; Mandosi E; Di Mario U; Morano S
    Diabetes Nutr Metab; 2004 Apr; 17(2):90-4. PubMed ID: 15244100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy.
    Song Z; Sun M; Zhou F; Huang F; Qu J; Chen D
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1229-34. PubMed ID: 24531563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane.
    Vriese AS; Tilton RG; Stephan CC; Lameire NH
    J Am Soc Nephrol; 2001 Aug; 12(8):1734-1741. PubMed ID: 11461947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.
    Ved N; Da Vitoria Lobo ME; Bestall SM; L Vidueira C; Beazley-Long N; Ballmer-Hofer K; Hirashima M; Bates DO; Donaldson LF; Hulse RP
    J Physiol; 2018 Aug; 596(16):3675-3693. PubMed ID: 29774557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.
    Buraczynska M; Ksiazek P; Baranowicz-Gaszczyk I; Jozwiak L
    Nephrol Dial Transplant; 2007 Mar; 22(3):827-32. PubMed ID: 17121786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.